Skip to main content
Fig. 2 | BMC Urology

Fig. 2

From: Cost implications of PSA screening differ by age

Fig. 2

Change in the percentage of total costs of prostate cancer screening, diagnosis, treatment, and associated complications as a function of PSA screening prevalence among eligible men. Observed screening prevalence at the multispecialty group is represented by the point each line intersects with the x-axis

Back to article page

BMC Urology

ISSN: 1471-2490

Contact us